PRO-DEX, INC. Capital Expenditures
PRO-DEX, INC. (PDEX) reported Capital Expenditures of $483.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-09-03
- PRO-DEX, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $203.00K, a 118.28% increase year-over-year.
- PRO-DEX, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $112.00K, a 37.78% decline year-over-year.
- PRO-DEX, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $70.00K, a 87.08% decline year-over-year.
- PRO-DEX, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $98.00K, a 77.26% decline year-over-year.
- PRO-DEX, INC. payments to acquire property, plant, and equipment for fiscal 2026 was $483.00K, a 61.24% decline from fiscal 2025.
- PRO-DEX, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $1.25M.
- PRO-DEX, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $1.64M, a 7.41% decline from fiscal 2021.
- PRO-DEX, INC. payments to acquire property, plant, and equipment for fiscal 2021 was $1.77M, a 240.85% increase from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 0 month | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | $315.00K derived: sum of 2 quarters · filed 2026-09-03 | $385.00K derived: sum of 3 quarters · filed 2026-09-03 | $483.00K 10-K · filed 2026-09-03 | |
| 2026-03-31 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $182.00K derived: sum of 2 quarters · filed 2026-04-30 | $280.00K 10-Q · filed 2026-04-30 | $373.00K derived: sum of 4 quarters · filed 2026-09-03 | |
| 2025-12-31 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $168.00K 10-Q · filed 2026-01-29 | $261.00K derived: sum of 3 quarters · filed 2026-09-03 | $441.00K derived: sum of 4 quarters · filed 2026-09-03 | |
| 2025-09-30 | $98.00K 10-Q · filed 2025-10-30 | $191.00K derived: sum of 2 quarters · filed 2026-09-03 | $371.00K derived: sum of 3 quarters · filed 2026-09-03 | $913.00K derived: sum of 4 quarters · filed 2026-09-03 | |
| 2025-06-30 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-03 | $273.00K derived: sum of 2 quarters · filed 2026-09-03 | $815.00K derived: sum of 3 quarters · filed 2026-09-03 | $1.25M 10-K · filed 2026-09-03 | |
| 2025-03-31 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-30 | $722.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.15M 10-Q · filed 2026-04-30 | ||
| 2024-12-31 | $542.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-29 | $973.00K 10-Q · filed 2026-01-29 | |||
| 2024-09-30 | $431.00K 10-Q · filed 2025-10-30 | ||||
| 2024-03-31 | $117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-01 | $750.00K derived: sum of 2 quarters · filed 2025-05-01 | $876.00K 10-Q · filed 2025-05-01 | ||
| 2023-12-31 | $633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-30 | $759.00K 10-Q · filed 2025-01-30 | |||
| 2023-09-30 | $126.00K 10-Q · filed 2024-10-31 | ||||
| 2023-03-31 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-02 | $644.00K derived: sum of 2 quarters · filed 2024-05-02 | $822.00K 10-Q · filed 2024-05-02 | $1.19M derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | $509.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-08 | $687.00K 10-Q · filed 2024-02-08 | $1.05M derived: sum of 3 quarters · filed 2024-02-08 | $1.25M derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-09-30 | $178.00K 10-Q · filed 2023-11-02 | $546.00K derived: sum of 2 quarters · filed 2023-11-02 | $744.00K derived: sum of 3 quarters · filed 2023-11-02 | $968.00K derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-08 | $566.00K derived: sum of 2 quarters · filed 2023-05-04 | $790.00K derived: sum of 3 quarters · filed 2023-05-04 | $1.64M 10-K · filed 2022-09-08 | |
| 2022-03-31 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-04 | $422.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.27M 10-Q · filed 2023-05-04 | ||
| 2021-12-31 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | $1.07M 10-Q · filed 2023-02-02 | |||
| 2021-09-30 | $848.00K 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | $1.77M 10-K · filed 2022-09-08 | ||||
| 2020-12-31 | $227.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-04 | $316.00K 10-Q · filed 2021-02-04 | |||
| 2020-11-06 | $6.50M 10-Q · filed 2023-05-04 | ||||
| 2020-09-30 | $89.00K 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | $519.00K 10-K · filed 2021-09-09 | ||||
| 2019-09-30 | $61.00K 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | $1.39M 10-K · filed 2020-09-10 | ||||
| 2018-09-30 | $477.00K 10-Q · filed 2019-11-07 | ||||
| 2018-03-31 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $681.00K derived: sum of 2 quarters · filed 2018-05-10 | $820.00K 10-Q · filed 2018-05-10 | ||
| 2017-12-31 | $574.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $713.00K 10-Q · filed 2018-02-08 | |||
| 2017-09-30 | $139.00K 10-Q · filed 2018-11-08 | ||||
| 2017-03-31 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $236.00K derived: sum of 2 quarters · filed 2018-05-10 | $552.00K 10-Q · filed 2018-05-10 | ||
| 2016-12-31 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $376.00K 10-Q · filed 2018-02-08 | |||
| 2016-09-30 | $316.00K 10-Q · filed 2017-11-09 | ||||
| 2016-03-31 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $106.00K 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $21.00K 10-Q · filed 2017-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |